COMPARATIVE EVALUATION OF THE EFFECTIVENESS OF INNOVATIVE HIGH-TECH CARDIAC SURGERY IN PATIENTS WHO HAVE SUFFERED AN

U Chulpanov1, B Turdaliyeva2, M Buleshov3

  • 11Kazakh National Medical University named after S.D. Asfendiyarov, Almaty, Kazakhstan.

Georgian Medical News
|October 23, 2024
PubMed

Insights

Innovative high-tech cardiac surgery significantly reduces mortality in myocardial infarction patients. While effective across age groups, the most substantial benefit was observed in elderly patients receiving these advanced cardiac procedures.

Area of Science:

  • Cardiovascular Surgery
  • Medical Technology Assessment
  • Public Health

Background:

  • Acute myocardial infarction (heart attack) poses a significant mortality risk.
  • Innovative high-tech cardiac surgery aims to improve patient outcomes.
  • Evaluating the effectiveness of these advanced cardiac procedures is crucial for healthcare policy.

Purpose of the Study:

  • To assess the medical and social effectiveness of innovative high-tech cardiac surgery for acute myocardial infarction patients.
  • To compare inpatient mortality rates between patients receiving and not receiving these advanced cardiac interventions.
  • To analyze the impact of these surgeries across different age demographics, particularly the elderly.

Main Methods:

  • Comprehensive assessment including medical-statistical, sociological, financial-economic, and organizational methods.
  • Logarithmic test analysis to evaluate the impact of specific procedures like stenting and bypass surgery.
  • Comparative analysis of hospital mortality rates between intervention and control groups.

Main Results:

  • High-tech cardiac surgery, including stenting and aorta-coronary bypass, significantly reduces hospital mortality in myocardial infarction patients (0.96% vs. 11.84%, p=0.002).
  • The greatest reduction in hospital mortality was observed in elderly patients who underwent these advanced cardiac procedures.
  • No significant mortality reduction was found in the elderly group when analyzed separately (p=0.779), indicating a nuanced effect within this demographic.

Conclusions:

  • Innovative high-tech cardiac surgery demonstrates significant effectiveness in reducing mortality post-myocardial infarction.
  • The success of these advanced cardiac procedures is contingent upon the availability of skilled cardiac surgeons and robust medical infrastructure.
  • Further research may be needed to fully elucidate the impact on specific elderly subgroups.